19-10986547-C-T
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001387283.1(SMARCA4):c.714C>T(p.Pro238=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,539,238 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P238P) has been classified as Likely benign.
Frequency
Consequence
NM_001387283.1 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SMARCA4 | NM_001387283.1 | c.714C>T | p.Pro238= | synonymous_variant | 4/36 | ENST00000646693.2 | |
SMARCA4 | NM_003072.5 | c.714C>T | p.Pro238= | synonymous_variant | 4/35 | ENST00000344626.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.714C>T | p.Pro238= | synonymous_variant | 4/36 | NM_001387283.1 | |||
SMARCA4 | ENST00000344626.10 | c.714C>T | p.Pro238= | synonymous_variant | 4/35 | 1 | NM_003072.5 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000987 AC: 15AN: 151940Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000223 AC: 3AN: 134578Hom.: 0 AF XY: 0.0000272 AC XY: 2AN XY: 73544
GnomAD4 exome AF: 0.0000195 AC: 27AN: 1387298Hom.: 1 Cov.: 34 AF XY: 0.0000175 AC XY: 12AN XY: 684698
GnomAD4 genome AF: 0.0000987 AC: 15AN: 151940Hom.: 0 Cov.: 32 AF XY: 0.0000943 AC XY: 7AN XY: 74206
ClinVar
Submissions by phenotype
Rhabdoid tumor predisposition syndrome 2 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 18, 2024 | - - |
Hereditary cancer-predisposing syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 16, 2017 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at